Studies by Wu et al. and Xing et al. demonstrate the rise in the levels of C3a, C5a, soluble C5b-9 in patients with ANCA-vasculitis, compared to healthy individuals, further highlighting the complement’s contribution. This evidence concerns the gene C3 and vasculitis.